James Damewood - Concepedia

Author

James Damewood

Also Known As

Damewood, James, J. Damewood, J. R. DAMEWOOD, J. R. Damewood, James Damewood, James R Damewood, James R. Damewood, James R. Damewood,, James R. Jr. Damewood

Publications

834

Citations

H-Index

Concepts

All Affiliations

Wilmington University AstraZeneca (United States)Massachusetts Institute of Technology DuPont (United States)

About

James Damewood is an author at Wilmington University specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	385
2	Natural Sciences	4	4	197
3	Engineering	2	2	116
4	Allergy	2	2	65
5	Public Health	1	1	12

James Damewood

Publications

699

Citations

H-Index

Page 1

	Year	Citations
Learning Matter: Materials Design with Machine Learning and Atomistic Simulations Simon Axelrod, Daniel Schwalbe‐Koda, Somesh Mohapatra, Accounts of Materials Research	2022	100
Representations of Materials for Machine Learning James Damewood, Jessica Karaguesian, Jaclyn R. Lunger, Annual Review of Materials Research Artificial IntelligenceMaterials ScienceMaterials Science VaryEngineeringMachine Learning	2023	94
Orally Active Trifluoromethyl Ketone Inhibitors of Human Leukocyte Elastase Chris A. Veale, Peter R Bernstein, Claudia Bohnert, Journal of Medicinal Chemistry Medicinal ChemistryOral BioavailabilityPharmaceutical ScienceBiochemistryHuman Leukocyte Elastase	1997	70
Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and x-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketones Chris A. Veale, Peter R Bernstein, Craig Bryant, Journal of Medicinal Chemistry X-ray CrystallographyPharmaceutical ScienceDrug TargetHuman Leukocyte ElastaseAltmetric Attention Score	1995	60
Non-peptidic inhibitors of human leukocyte elastase. 4. Design, synthesis, and in vitro and in vivo activity of a series of .beta.-carbolinone-containing trifluoromethyl ketones Chris A. Veale, James Damewood, Gary B. Steelman, Journal of Medicinal Chemistry	1995	55
Nonpeptidic Inhibitors of Human Leukocyte Elastase. 3. Design, Synthesis, X-ray Crystallographic Analysis, and Structure-Activity Relationships for a Series of Orally Active 3-Amino-6-phenyl-2-pyridinyl Trifluoromethyl Ketones Peter R Bernstein, Donald W. Andisik, Prudence K. Bradley, Journal of Medicinal Chemistry Pharmaceutical ScienceHuman Leukocyte ElastasePharmacotherapyChemical BiologyPharmaceutical Chemistry	1994	54
Development and SAR of functionally selective allosteric modulators of GABAA receptors Cristóbal Alhambra, Chris Becker, Timothy J. Blake, Bioorganic & Medicinal Chemistry Selective Allosteric ModulatorsSignal TransductionBiochemistryFunctional SelectivityMedicine	2011	51
Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase Frederick J. Brown, Donald W. Andisik, Peter R Bernstein, Journal of Medicinal Chemistry ImmunologyAltmetric Attention ScorePharmacotherapyImmunotherapyPre-clinical Pharmacology	1994	48
The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. part 1 Chris A. Veale, Vernon Alford, David Aharony, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPart 1Cardiovascular DiseaseMedicinePhysiology	2000	44
Nonpeptidic Inhibitors of Human Leukocyte Elastase. 2. Design, Synthesis, and in vitro Activity of a Series of 3-Amino-6-aryl-2-oxopyridyl Trifluoromethyl Ketones James Damewood, Philip D. Edwards, Scott W. Feeney, Journal of Medicinal Chemistry	1994	30

Page 1